Obesity Clinical Trial
Official title:
Evaluation of Dietary Supplements (Shakes and Supplements) and Personal Energy Tracking Device to Promote and Maintain Healthy Weight
| Verified date | March 2008 |
| Source | Pharmanex |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
Excessive body weight is becoming a concern around the world, for example over half of the
American adult population is overweight or obese. The purpose of this study is to determine
whether dietary supplements and shakes containing a combination of nutrients/ingredients
individually shown in research studies to reduce hunger, enhance metabolism, reduce the
body's ability to 'store' fat, and enhance energy, promote healthy body weight and
composition over 12 weeks. A further study objective is to determine whether the inclusion
of a personal, easy to use, energy tracking device for the measurement of daily energy
intake and expenditure also helps with the promotion of healthy body weight and body
composition.
In this prospective, blinded study 120 volunteers who meet the entrance criteria including a
BMI 25-35 kg/m2 and sign the informed consent form to participate in a 12 week long study
will be recruited. All subjects will consume a multi-vitamin, mineral and fish oil
supplement. Subjects will be randomly assigned to a control or experimental group and
stratified by BMI 25-30 and >30-35 kg/m2, age, and gender with an equal number of subjects
in each strata across groups. A subset of subjects will also wear a personal energy tracking
device. Subjects will be instructed how to incorporate the shakes and supplements into their
current diet and encouraged to incorporate fruits, vegetables, whole grains, and other
healthy foods into their current meals and to exercise at least 30 minutes five days per
week.
| Status | Completed |
| Enrollment | 120 |
| Est. completion date | December 2007 |
| Est. primary completion date | December 2007 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 18 Years to 65 Years |
| Eligibility |
Inclusion Criteria: - Between the ages of 18-65 years of age. - Body Mass Index (BMI) between 25-35 - Willing to stop taking any nutritional supplements Exclusion Criteria: - Currently taking weight loss medication or supplements - Currently smoke - Taking any prescription medications - Experienced at least a 10 pound weight loss over the past 2 months. - History of serious heart problems (i.e. heart attack, angina, bypass surgery). - Diagnosed with diabetes (insulin or non-insulin dependent) - Known history of gastrointestinal diseases (i.e. Crohn's disease, chronic diarrhea, Inflammatory Bowel Disease) - Undergone surgical procedure for weight loss (i.e. gastroplasty, gastric by-pass, gastrectomy, stomach stapling, gastric banding, etc). - History of stroke or seizure activity - Medical conditions known to affect serum lipids - History of uncontrolled hypertension or with a current measured blood pressure with diastolic above 90 or systolic above 140 mm Hg - A total serum cholesterol above 240 mg/dL - Known HIV infection - Known history of depression and currently taking anti-depression medications - Treated for cancer in the last 5 years - Known allergies to supplements - Known history of eating disorder (i.e. bulimia, anorexia nervosa) - Known severe swallowing disorders - For females, known to be pregnant or breast-feeding or trying to become pregnant - Participating in another clinical (medical or nutritional) study or likely to be enrolled in another medical or nutritional protocol during this study |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind
| Country | Name | City | State |
|---|---|---|---|
| United States | Pharmanex | Provo | Utah |
| Lead Sponsor | Collaborator |
|---|---|
| Pharmanex |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Body weight changes | Several measurements over 12 weeks | ||
| Secondary | Biophotonic scanner score, blood chemistry and metabolic profiles, adverse events, subjects' supplement preference, quality of life measurements | Several measurements over 12 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |